Klotho Neurosciences Inc/$KLTO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Klotho Neurosciences Inc
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
Ticker
$KLTO
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
3
ISIN
US49876K1034
Website
KLTO Metrics
BasicAdvanced
$5.9M
-
-$0.35
0.02
-
Price and volume
Market cap
$5.9M
Beta
0.02
52-week high
$0.57
52-week low
$0.11
Average daily volume
23M
Financial strength
Current ratio
0.294
Quick ratio
0.242
Total debt to equity
276.796
Interest coverage (TTM)
-7.09%
Management effectiveness
Return on assets (TTM)
-151.41%
Return on equity (TTM)
-1,544.44%
Valuation
Price to book
8.12
Price to tangible book (TTM)
-3.12
Price to free cash flow (TTM)
-0.908
Growth
Earnings per share change (TTM)
28,646.17%
3-year earnings per share growth (CAGR)
568.81%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Klotho Neurosciences Inc stock?
Klotho Neurosciences Inc (KLTO) has a market cap of $5.9M as of May 31, 2025.
What is the P/E ratio for Klotho Neurosciences Inc stock?
The price to earnings (P/E) ratio for Klotho Neurosciences Inc (KLTO) stock is 0 as of May 31, 2025.
Does Klotho Neurosciences Inc stock pay dividends?
No, Klotho Neurosciences Inc (KLTO) stock does not pay dividends to its shareholders as of May 31, 2025.
When is the next Klotho Neurosciences Inc dividend payment date?
Klotho Neurosciences Inc (KLTO) stock does not pay dividends to its shareholders.
What is the beta indicator for Klotho Neurosciences Inc?
Klotho Neurosciences Inc (KLTO) has a beta rating of 0.02. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.